133 related articles for article (PubMed ID: 8230095)
21. Platelet-activating factor acts on cortisol secretion by perfused guinea-pig adrenals via calcium-/phospholipid-dependent mechanisms.
Shimada T; Hirose T; Matsumoto I; Aikawa T
J Endocrinol; 2005 Feb; 184(2):381-91. PubMed ID: 15684346
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of the PAF receptor antagonist UK-74,505 on neutrophil and eosinophil accumulation in guinea-pig skin.
Sanz MJ; Weg VB; Walsh DT; Williams TJ; Nourshargh S
Br J Pharmacol; 1994 Oct; 113(2):513-21. PubMed ID: 7834203
[TBL] [Abstract][Full Text] [Related]
23. Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects.
Shen TY; Hwang SB; Chang MN; Doebber TW; Lam MH; Wu MS; Wang X; Han GQ; Li RZ
Proc Natl Acad Sci U S A; 1985 Feb; 82(3):672-6. PubMed ID: 2983307
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and structure-activity relationships of a series of novel benzopyran-containing platelet activating factor antagonists.
Guinn DE; Summers JB; Heyman HR; Conway RG; Rhein DA; Albert DH; Magoc T; Carter GW
J Med Chem; 1992 May; 35(11):2055-61. PubMed ID: 1317924
[TBL] [Abstract][Full Text] [Related]
25. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.
Imanishi N; Murakami-Uchida M; Koike H; Natsume Y; Morooka S
Arzneimittelforschung; 1994 Mar; 44(3):317-22. PubMed ID: 8192697
[TBL] [Abstract][Full Text] [Related]
26. Characterization of specific binding sites of 3H-labelled platelet-activating factor ([3H]PAF) and a new antagonist, [3H]SR 27417, on guinea-pig tracheal epithelial cells.
Herbert JM
Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):201-6. PubMed ID: 1318021
[TBL] [Abstract][Full Text] [Related]
27. Species difference in the specific receptors of platelet activating factor.
Hwang SB; Lam MH
Biochem Pharmacol; 1986 Dec; 35(24):4511-8. PubMed ID: 3024653
[TBL] [Abstract][Full Text] [Related]
28. (+/-)-trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5- trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonist.
Ponpipom MM; Hwang SB; Doebber TW; Acton JJ; Alberts AW; Biftu T; Brooker DR; Bugianesi RL; Chabala JC; Gamble NL
Biochem Biophys Res Commun; 1988 Feb; 150(3):1213-20. PubMed ID: 2829894
[TBL] [Abstract][Full Text] [Related]
29. Platelet-activating factor antagonists: scientific background and possible clinical applications.
Koltai M; Guinot P; Hosford D; Braquet PG
Adv Pharmacol; 1994; 28():81-167. PubMed ID: 8080821
[No Abstract] [Full Text] [Related]
30. Platelet-activating factor mediates the ozone-induced increase in airway microvascular leakage in guinea pigs.
Kaneko T; Ikeda H; Fu L; Nishiyama H; Okubo T
Eur J Pharmacol; 1995 Mar; 292(3-4):251-5. PubMed ID: 7796863
[TBL] [Abstract][Full Text] [Related]
31. [3H]WEB 2086 labels platelet activating factor receptors in guinea pig and human lung.
Dent G; Ukena D; Sybrecht GW; Barnes PJ
Eur J Pharmacol; 1989 Oct; 169(2-3):313-6. PubMed ID: 2553451
[TBL] [Abstract][Full Text] [Related]
32. Presence of specific platelet-activating factor binding-sites in neuroblastoma N1E-115 cells.
Lalouette F; Diserbo M; Martin C; Verdetti J; Fatome M
Neurosci Lett; 1995 Feb; 186(2-3):173-6. PubMed ID: 7777190
[TBL] [Abstract][Full Text] [Related]
33. Anti-inflammatory activities of LDP-392, a dual PAF receptor antagonist and 5-lipoxygenase inhibitor.
Qian C; Hwang SB; Libertine-Garahan L; Eckman JB; Cai X; Scannell RT; Yeh CG
Pharmacol Res; 2001 Sep; 44(3):213-20. PubMed ID: 11529688
[TBL] [Abstract][Full Text] [Related]
34. Preparation of 7-substituted ginkgolide derivatives: potent platelet activating factor (PAF) receptor antagonists.
Vogensen SB; Strømgaard K; Shindou H; Jaracz S; Suehiro M; Ishii S; Shimizu T; Nakanishi K
J Med Chem; 2003 Feb; 46(4):601-8. PubMed ID: 12570381
[TBL] [Abstract][Full Text] [Related]
35. ABT-299, a potent antagonist of platelet activating factor.
Summers JB; Albert DH; Davidsen SK; Conway RG; Holms JH; Magoc TJ; Luo G; Tapang P; Rhein DA; Carter GW
Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():475-7. PubMed ID: 7732895
[No Abstract] [Full Text] [Related]
36. [3H]52770 RP, a platelet-activating factor receptor antagonist, and tritiated platelet-activating factor label a common specific binding site in human polymorphonuclear leukocytes.
Marquis O; Robaut C; Cavero I
J Pharmacol Exp Ther; 1988 Feb; 244(2):709-15. PubMed ID: 2831350
[TBL] [Abstract][Full Text] [Related]
37. Characterization of receptors for platelet-activating factor in guinea pig lung membranes.
Gomez J; Bloom JW; Yamamura HI; Halonen M
Am J Respir Cell Mol Biol; 1990 Sep; 3(3):259-64. PubMed ID: 2167700
[TBL] [Abstract][Full Text] [Related]
38. Hetrazepine PAF antagonists.
Ikegami K; Meade CJ; Heuer HO; Birke F
J Lipid Mediat; 1992; 5(2):177-82. PubMed ID: 1326346
[TBL] [Abstract][Full Text] [Related]
39. The isolation and characterization of kadsurenone from haifenteng (Piper futokadsura) as an orally active specific receptor antagonist of platelet-activating factor.
Shen TY; Hwang SB; Chang MN; Doebber TW; Lam MH; Wu MS; Wang X
Int J Tissue React; 1985; 7(5):339-43. PubMed ID: 2997065
[TBL] [Abstract][Full Text] [Related]
40. Structure-activity relationships in platelet-activating factor (PAF). 10. From PAF antagonism to inhibition of HIV-1 replication.
Serradji N; Bensaid O; Martin M; Kan E; Dereuddre-Bosquet N; Redeuilh C; Huet J; Heymans F; Lamouri A; Clayette P; Dong CZ; Dormont D; Godfroid JJ
J Med Chem; 2000 Jun; 43(11):2149-54. PubMed ID: 10841793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]